FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.”
The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.
NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.
